Medifast(MED) - 2020 Q3 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR 100 International Drive OF 1934 For the transition period from to . Baltimore, Maryland 21202 Telephone Number: (410) 581-8042 Commission File Number: 001-31573 Medifast, Inc. (Exact name of registrant as specified in its charter) Delaware 13-3714405 ☐ TRANSITION REPOR ...